Remdesivir Market Share According to MRFR analysis, Global Remdesivir Market Share is expected to register a CAGR of 31.2% during the forecast period of 2020 to 2027 and reach USD 10,119.99 Million by 2027. Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that...

Remdesivir Market Share Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. The growth of the global Remdesivir (COVID 19) market can be contributed to the growing need for rescue medication, including remdesivir drugs, due...

Remdesivir Market Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. The growth of the global Remdesivir (COVID 19) market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to...